FY2025 · ended Dec 31, 2025 · Revenue $8.98M, +28.1% YoY · Filed Mar 18, 2026
InspireMD, Inc. (NSPR) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $9.0 million and a net loss of $48.8 million. Free cash flow was -$36.8 million. As of Jun 30, 2026 it held $30.4 million in cash and investments and $2.0 million in total debt.
Revenue (TTM)
$10.84M
+53.4% vs year-ago TTM
Net income (TTM)
$-52.48M
-26.8% vs year-ago TTM
Operating cash flow (TTM)
$-41.21M
-39.3% vs year-ago TTM
Free cash flow (TTM)
$-42.46M
-35.9% vs year-ago TTM
EPS (TTM)
$-0.65
+22.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
46.80M
+57.6% vs prior year
Net cash
$28.45M
as of Jun 30, 2026
Operating margin
-494.0%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NSPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1433607
- Former names
- Saguaro Resources, Inc. (until Apr 1, 2011)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M | $4.5M |
| Operating income | -$49.6M | -$33.5M | -$21.1M | -$18.7M | -$14.7M |
| Net income | -$48.8M | -$32.0M | -$19.9M | -$18.5M | -$14.9M |
| Diluted EPS | -$0.76 | -$0.76 | -$0.82 | — | — |
| Operating cash flow | -$35.1M | -$21.9M | -$16.4M | -$15.5M | -$13.2M |
| Free cash flow | -$36.8M | -$23.3M | -$16.8M | -$16.0M | -$13.6M |
| Total assets | $69.4M | $46.8M | $47.6M | $24.7M | $39.7M |
| Total liabilities | $14.2M | $10.7M | $8.1M | $7.3M | $6.2M |
| Stockholders' equity | $55.2M | $36.1M | $39.5M | $17.4M | $33.5M |
| Cash and investments | $54.2M | $34.6M | $39.0M | $4.6M | $12.0M |
| Total debt | $3.3M | $2.3M | $2.3M | $1.6M | $1.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2026 | Jun 26, 2026 |
All 1000 InspireMD, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.